Vaxxinity, Inc.
VAXX
$0.0002
-$0.0153-98.71%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -20.88% | -47.68% | -43.77% | -42.11% | -45.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.23% | -34.40% | -34.93% | -37.72% | -39.29% |
| Operating Income | 23.23% | 34.40% | 34.90% | 37.70% | 39.25% |
| Income Before Tax | 24.31% | 35.69% | 36.62% | 38.92% | 45.16% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 24.31% | 35.69% | 36.62% | 38.92% | 45.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.31% | 35.69% | 36.62% | 38.92% | 45.16% |
| EBIT | 23.23% | 34.40% | 34.90% | 37.70% | 39.25% |
| EBITDA | 24.50% | 35.83% | 36.02% | 38.70% | 40.07% |
| EPS Basic | 24.69% | 42.69% | 52.42% | 58.92% | 66.40% |
| Normalized Basic EPS | 24.67% | 42.70% | 52.42% | 58.93% | 66.41% |
| EPS Diluted | 24.69% | 42.69% | 52.42% | 58.92% | 66.40% |
| Normalized Diluted EPS | 24.67% | 42.70% | 52.42% | 58.93% | 66.41% |
| Average Basic Shares Outstanding | 0.55% | 5.71% | 19.94% | 38.69% | 64.45% |
| Average Diluted Shares Outstanding | 0.55% | 5.71% | 19.94% | 38.69% | 64.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |